Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prime Medicine (PRME) Change in Acquisitions & Divestments: 2021-2024

Historic Change in Acquisitions & Divestments for Prime Medicine (PRME) over the last 4 years, with Dec 2024 value amounting to $204.2 million.

  • Prime Medicine's Change in Acquisitions & Divestments fell 30.78% to $42.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $89.6 million, marking a year-over-year decrease of 59.06%. This contributed to the annual value of $204.2 million for FY2024, which is 54.05% up from last year.
  • According to the latest figures from FY2024, Prime Medicine's Change in Acquisitions & Divestments is $204.2 million, which was up 54.05% from $132.6 million recorded in FY2023.
  • Prime Medicine's Change in Acquisitions & Divestments' 5-year high stood at $204.2 million during FY2024, with a 5-year trough of $13.0 million in FY2021.
  • Over the past 3 years, Prime Medicine's median Change in Acquisitions & Divestments value was $132.6 million (recorded in 2023), while the average stood at $143.3 million.
  • Data for Prime Medicine's Change in Acquisitions & Divestments shows a peak YoY skyrocketed of 615.38% (in 2022) over the last 5 years.
  • Over the past 4 years, Prime Medicine's Change in Acquisitions & Divestments (Yearly) stood at $13.0 million in 2021, then soared by 615.38% to $93.0 million in 2022, then spiked by 42.53% to $132.6 million in 2023, then soared by 54.05% to $204.2 million in 2024.